FLT3 ITD are independent predictors of bad prognosis in cytogenetically normal (CN-) AML and they represent a challenge of great interest, due to the high frequency and to the availability of specific inhibitors [3–5]. Here, FLT3 is linked to acute myeloid leukemia.